학술논문
Selective Polo-like Kinase 1 (PLK1) inhibitor PCM-075 is highly active alone and shows synergy when combined with FLT3 inhibitors in models of acute myeloid leukemia (AML)
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
15387445